APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade CBD Oil

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025194 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade CBD Oil Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade CBD Oil market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Grade CBD Oil include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade CBD Oil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade CBD Oil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade CBD Oil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade CBD Oil market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade CBD Oil Segment by Company

Absolute Terps

Aphria

Cannavest

Canopy Growth Corporation

CBD American Shaman

Charlotte's Web

Emblem Cannabis Oils

ENDOCA

Folium Biosciences

GL Brands, Inc.

Green Road

HempLife Today

K.I.N.D. Concentrates

Kazmira

Medical Marijuana, Inc.

NuLeaf Naturals

PHARM-CBD, LLC

The Lab

Whistler

Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil

Broad Spectrum CBD Oil

Pharmaceutical Grade CBD Oil Segment by Application

Anxiety

Diabetes

Fibromyalgia

Others

Pharmaceutical Grade CBD Oil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade CBD Oil market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade CBD Oil Industry Trends Table 2. Pharmaceutical Grade CBD Oil Industry Drivers Table 3. Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges Table 4. Pharmaceutical Grade CBD Oil Industry Restraints Table 5. Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical Grade CBD Oil Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Pharmaceutical Grade CBD Oil Sales Market Share by Manufacturers Table 9. Global Pharmaceutical Grade CBD Oil Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical Grade CBD Oil Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical Grade CBD Oil Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical Grade CBD Oil Manufacturers, Product Type & Application Table 13. Global Pharmaceutical Grade CBD Oil Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade CBD Oil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Full Spectrum CBD Oil Table 17. Major Manufacturers of Broad Spectrum CBD Oil Table 18. Global Pharmaceutical Grade CBD Oil Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 20. Global Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 21. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2026) Table 22. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2027-2032) Table 23. Global Pharmaceutical Grade CBD Oil Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (Tons) Table 25. Global Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (Tons) Table 26. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2026) Table 27. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Anxiety Table 29. Major Manufacturers of Diabetes Table 30. Major Manufacturers of Fibromyalgia Table 31. Major Manufacturers of Others Table 32. Global Pharmaceutical Grade CBD Oil Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 34. Global Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 35. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2027-2032) Table 37. Global Pharmaceutical Grade CBD Oil Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (Tons) Table 39. Global Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (Tons) Table 40. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2026) Table 41. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2027-2032) Table 42. Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (Tons) Table 44. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2026) Table 45. Global Pharmaceutical Grade CBD Oil Sales Forecasted by Region (2027-2032) & (Tons) Table 46. Global Pharmaceutical Grade CBD Oil Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 48. North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 49. North America Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 50. Europe Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 51. Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 52. Europe Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 53. Asia Pacific Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 55. Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 56. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 58. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 59. Global Pharmaceutical Grade CBD Oil Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pharmaceutical Grade CBD Oil Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pharmaceutical Grade CBD Oil Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2026) Table 63. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2027-2032) Table 64. Absolute Terps Company Information Table 65. Absolute Terps Business Overview Table 66. Absolute Terps Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio Table 68. Absolute Terps Recent Development Table 69. Aphria Company Information Table 70. Aphria Business Overview Table 71. Aphria Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Aphria Pharmaceutical Grade CBD Oil Product Portfolio Table 73. Aphria Recent Development Table 74. Cannavest Company Information Table 75. Cannavest Business Overview Table 76. Cannavest Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cannavest Pharmaceutical Grade CBD Oil Product Portfolio Table 78. Cannavest Recent Development Table 79. Canopy Growth Corporation Company Information Table 80. Canopy Growth Corporation Business Overview Table 81. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio Table 83. Canopy Growth Corporation Recent Development Table 84. CBD American Shaman Company Information Table 85. CBD American Shaman Business Overview Table 86. CBD American Shaman Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio Table 88. CBD American Shaman Recent Development Table 89. Charlotte's Web Company Information Table 90. Charlotte's Web Business Overview Table 91. Charlotte's Web Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio Table 93. Charlotte's Web Recent Development Table 94. Emblem Cannabis Oils Company Information Table 95. Emblem Cannabis Oils Business Overview Table 96. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio Table 98. Emblem Cannabis Oils Recent Development Table 99. ENDOCA Company Information Table 100. ENDOCA Business Overview Table 101. ENDOCA Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio Table 103. ENDOCA Recent Development Table 104. Folium Biosciences Company Information Table 105. Folium Biosciences Business Overview Table 106. Folium Biosciences Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio Table 108. Folium Biosciences Recent Development Table 109. GL Brands, Inc. Company Information Table 110. GL Brands, Inc. Business Overview Table 111. GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 113. GL Brands, Inc. Recent Development Table 114. Green Road Company Information Table 115. Green Road Business Overview Table 116. Green Road Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Green Road Pharmaceutical Grade CBD Oil Product Portfolio Table 118. Green Road Recent Development Table 119. HempLife Today Company Information Table 120. HempLife Today Business Overview Table 121. HempLife Today Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio Table 123. HempLife Today Recent Development Table 124. K.I.N.D. Concentrates Company Information Table 125. K.I.N.D. Concentrates Business Overview Table 126. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio Table 128. K.I.N.D. Concentrates Recent Development Table 129. Kazmira Company Information Table 130. Kazmira Business Overview Table 131. Kazmira Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Kazmira Pharmaceutical Grade CBD Oil Product Portfolio Table 133. Kazmira Recent Development Table 134. Medical Marijuana, Inc. Company Information Table 135. Medical Marijuana, Inc. Business Overview Table 136. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 138. Medical Marijuana, Inc. Recent Development Table 139. NuLeaf Naturals Company Information Table 140. NuLeaf Naturals Business Overview Table 141. NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio Table 143. NuLeaf Naturals Recent Development Table 144. PHARM-CBD, LLC Company Information Table 145. PHARM-CBD, LLC Business Overview Table 146. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio Table 148. PHARM-CBD, LLC Recent Development Table 149. The Lab Company Information Table 150. The Lab Business Overview Table 151. The Lab Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. The Lab Pharmaceutical Grade CBD Oil Product Portfolio Table 153. The Lab Recent Development Table 154. Whistler Company Information Table 155. Whistler Business Overview Table 156. Whistler Pharmaceutical Grade CBD Oil Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Whistler Pharmaceutical Grade CBD Oil Product Portfolio Table 158. Whistler Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Pharmaceutical Grade CBD Oil Distributors List Table 162. Pharmaceutical Grade CBD Oil Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Pharmaceutical Grade CBD Oil Product Image Figure 2. Global Pharmaceutical Grade CBD Oil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade CBD Oil Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade CBD Oil Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceutical Grade CBD Oil Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Full Spectrum CBD Oil Image Figure 9. Broad Spectrum CBD Oil Image Figure 10. Global Pharmaceutical Grade CBD Oil Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Pharmaceutical Grade CBD Oil Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032) Figure 13. Global Pharmaceutical Grade CBD Oil Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Pharmaceutical Grade CBD Oil Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032) Figure 16. Anxiety Image Figure 17. Diabetes Image Figure 18. Fibromyalgia Image Figure 19. Others Image Figure 20. Global Pharmaceutical Grade CBD Oil Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Pharmaceutical Grade CBD Oil Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032) Figure 23. Global Pharmaceutical Grade CBD Oil Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Pharmaceutical Grade CBD Oil Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 27. North America Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 28. U.S. Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Canada Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Mexico Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 33. Germany Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 34. France Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 35. U.K. Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Italy Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Netherlands Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 40. China Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Japan Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 42. South Korea Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Southeast Asia Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 44. India Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Australia Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 48. Brazil Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South Africa Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Saudi Arabia Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Turkey Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Argentina Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 53. UAE Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Egypt Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Chile Pharmaceutical Grade CBD Oil Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Global Pharmaceutical Grade CBD Oil Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Figure 59. North America Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pharmaceutical Grade CBD Oil Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pharmaceutical Grade CBD Oil Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
Applications
  • Anxiety
  • Diabetes
  • Fibromyalgia
  • Others
Companies covered
  • Absolute Terps
  • Aphria
  • Cannavest
  • Canopy Growth Corporation
  • CBD American Shaman
  • Charlotte's Web
  • Emblem Cannabis Oils
  • ENDOCA
  • Folium Biosciences
  • GL Brands, Inc.
  • Green Road
  • HempLife Today
  • K.I.N.D. Concentrates
  • Kazmira
  • Medical Marijuana, Inc.
  • NuLeaf Naturals
  • PHARM-CBD, LLC
  • The Lab
  • Whistler

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Grade CBD Oil Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Grade CBD Oil Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceutical Grade CBD Oil Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceutical Grade CBD Oil Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceutical Grade CBD Oil Market Dynamics
  1. 2.1 Pharmaceutical Grade CBD Oil Industry Trends
  2. 2.2 Pharmaceutical Grade CBD Oil Industry Drivers
  3. 2.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade CBD Oil Industry Restraints
3 Pharmaceutical Grade CBD Oil Market by Manufacturers
  1. 3.1 Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical Grade CBD Oil Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Grade CBD Oil Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Grade CBD Oil Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Grade CBD Oil Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical Grade CBD Oil Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical Grade CBD Oil Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Grade CBD Oil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Grade CBD Oil Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade CBD Oil Market by Type
  1. 4.1 Pharmaceutical Grade CBD Oil Type Introduction
  2. 4.1.1 Full Spectrum CBD Oil
  3. 4.1.2 Broad Spectrum CBD Oil
  4. 4.2 Global Pharmaceutical Grade CBD Oil Sales by Type
  5. 4.2.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade CBD Oil Revenue by Type
  9. 4.3.1 Global Pharmaceutical Grade CBD Oil Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Grade CBD Oil Market by Application
  1. 5.1 Pharmaceutical Grade CBD Oil Application Introduction
  2. 5.1.1 Anxiety
  3. 5.1.2 Diabetes
  4. 5.1.3 Fibromyalgia
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Grade CBD Oil Sales by Application
  7. 5.2.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pharmaceutical Grade CBD Oil Revenue by Application
  11. 5.3.1 Global Pharmaceutical Grade CBD Oil Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  13. 5.3.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Grade CBD Oil Sales by Region
  1. 6.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceutical Grade CBD Oil Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceutical Grade CBD Oil Revenue by Region
  1. 7.1 Global Pharmaceutical Grade CBD Oil Revenue by Region
  2. 7.1.1 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceutical Grade CBD Oil Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceutical Grade CBD Oil Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceutical Grade CBD Oil Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceutical Grade CBD Oil Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Absolute Terps
  2. 8.1.1 Absolute Terps Company Information
  3. 8.1.2 Absolute Terps Business Overview
  4. 8.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
  6. 8.1.5 Absolute Terps Recent Developments
  7. 8.2 Aphria
  8. 8.2.1 Aphria Company Information
  9. 8.2.2 Aphria Business Overview
  10. 8.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
  12. 8.2.5 Aphria Recent Developments
  13. 8.3 Cannavest
  14. 8.3.1 Cannavest Company Information
  15. 8.3.2 Cannavest Business Overview
  16. 8.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
  18. 8.3.5 Cannavest Recent Developments
  19. 8.4 Canopy Growth Corporation
  20. 8.4.1 Canopy Growth Corporation Company Information
  21. 8.4.2 Canopy Growth Corporation Business Overview
  22. 8.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
  24. 8.4.5 Canopy Growth Corporation Recent Developments
  25. 8.5 CBD American Shaman
  26. 8.5.1 CBD American Shaman Company Information
  27. 8.5.2 CBD American Shaman Business Overview
  28. 8.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
  30. 8.5.5 CBD American Shaman Recent Developments
  31. 8.6 Charlotte's Web
  32. 8.6.1 Charlotte's Web Company Information
  33. 8.6.2 Charlotte's Web Business Overview
  34. 8.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
  36. 8.6.5 Charlotte's Web Recent Developments
  37. 8.7 Emblem Cannabis Oils
  38. 8.7.1 Emblem Cannabis Oils Company Information
  39. 8.7.2 Emblem Cannabis Oils Business Overview
  40. 8.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
  42. 8.7.5 Emblem Cannabis Oils Recent Developments
  43. 8.8 ENDOCA
  44. 8.8.1 ENDOCA Company Information
  45. 8.8.2 ENDOCA Business Overview
  46. 8.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
  48. 8.8.5 ENDOCA Recent Developments
  49. 8.9 Folium Biosciences
  50. 8.9.1 Folium Biosciences Company Information
  51. 8.9.2 Folium Biosciences Business Overview
  52. 8.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
  54. 8.9.5 Folium Biosciences Recent Developments
  55. 8.10 GL Brands, Inc.
  56. 8.10.1 GL Brands, Inc. Company Information
  57. 8.10.2 GL Brands, Inc. Business Overview
  58. 8.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  60. 8.10.5 GL Brands, Inc. Recent Developments
  61. 8.11 Green Road
  62. 8.11.1 Green Road Company Information
  63. 8.11.2 Green Road Business Overview
  64. 8.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
  66. 8.11.5 Green Road Recent Developments
  67. 8.12 HempLife Today
  68. 8.12.1 HempLife Today Company Information
  69. 8.12.2 HempLife Today Business Overview
  70. 8.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
  72. 8.12.5 HempLife Today Recent Developments
  73. 8.13 K.I.N.D. Concentrates
  74. 8.13.1 K.I.N.D. Concentrates Company Information
  75. 8.13.2 K.I.N.D. Concentrates Business Overview
  76. 8.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
  78. 8.13.5 K.I.N.D. Concentrates Recent Developments
  79. 8.14 Kazmira
  80. 8.14.1 Kazmira Company Information
  81. 8.14.2 Kazmira Business Overview
  82. 8.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
  84. 8.14.5 Kazmira Recent Developments
  85. 8.15 Medical Marijuana, Inc.
  86. 8.15.1 Medical Marijuana, Inc. Company Information
  87. 8.15.2 Medical Marijuana, Inc. Business Overview
  88. 8.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  90. 8.15.5 Medical Marijuana, Inc. Recent Developments
  91. 8.16 NuLeaf Naturals
  92. 8.16.1 NuLeaf Naturals Company Information
  93. 8.16.2 NuLeaf Naturals Business Overview
  94. 8.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
  96. 8.16.5 NuLeaf Naturals Recent Developments
  97. 8.17 PHARM-CBD, LLC
  98. 8.17.1 PHARM-CBD, LLC Company Information
  99. 8.17.2 PHARM-CBD, LLC Business Overview
  100. 8.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
  102. 8.17.5 PHARM-CBD, LLC Recent Developments
  103. 8.18 The Lab
  104. 8.18.1 The Lab Company Information
  105. 8.18.2 The Lab Business Overview
  106. 8.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
  108. 8.18.5 The Lab Recent Developments
  109. 8.19 Whistler
  110. 8.19.1 Whistler Company Information
  111. 8.19.2 Whistler Business Overview
  112. 8.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
  114. 8.19.5 Whistler Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade CBD Oil Production Mode & Process
  6. 9.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade CBD Oil Distributors
  9. 9.2.3 Pharmaceutical Grade CBD Oil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst